- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04083352
Ketone Supplementation in Individuals With PTSD
November 15, 2019 updated by: Augusta University
The Effects of Exogenous Ketone Supplementation or a Ketogenic Diet in Individuals With PTSD
The purpose of this study is to determine if a 6-week period of ketone salt supplementation affects physiological, emotional, cognitive, and/or behavioral health markers in individuals with PTSD.
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Georgia
-
Augusta, Georgia, United States, 30909
- Recruiting
- Augusta University
-
Contact:
- Angelia M Holland
- Phone Number: 706-731-7912
- Email: angholland@augusta.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosed with PTSD
Exclusion Criteria:
- Pregnant, younger than 18 or older than 65
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 6-week ketone supplementation
Participants took a ketomax ketone salt supplementation for 6-weeks.
They took 2 servings per day.
|
6-week supplementation with ketone salts
|
Placebo Comparator: 6-week placebo supplement
Participants took a placebo supplement for 6-weeks.
The placebo was calorie, sodium, and flavor-matched to the experimental supplement.
|
Placebo was taken for 6-weeks and was calorie and flavor matched to the ketone salt supplement.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Comprehensive Metabolic Panel
Time Frame: Pre- and Post- 6-week supplemental period
|
Blood health marker
|
Pre- and Post- 6-week supplemental period
|
Change in Complete Blood Count
Time Frame: Pre- and Post- 6-week supplemental period
|
Blood health marker
|
Pre- and Post- 6-week supplemental period
|
Change in Cognitive Performance
Time Frame: Pre- and Post- 6-week supplemental period
|
ANAM test battery
|
Pre- and Post- 6-week supplemental period
|
Change in Blood Pressure
Time Frame: Pre- and Post- 6-week supplemental period
|
Cardiovascular health measure
|
Pre- and Post- 6-week supplemental period
|
Change in Urinalysis
Time Frame: Pre- and Post- 6-week supplemental period
|
Health measure
|
Pre- and Post- 6-week supplemental period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Insomnia
Time Frame: Pre- and Post- 6-week supplemental period
|
Insomnia Severity Questionnaire
|
Pre- and Post- 6-week supplemental period
|
Change in Emotional Health
Time Frame: Pre- and Post- 6-week supplemental period
|
Title: 12-Item Grit Scale; Construct: measures trait-level perserverance and passion for long-term goals; the scale for each question includes the following answers to check: Very much like me, mostly like me, somewhat like me, not much like me, not like me at all; Scoring: for questions 1, 4, 6, 9, 10, and 12 the following answers receive the associated number as a score: Very much like me (5), Mostly like me (4), Somewhat like me (3), Not much like me (2), Not like me at all (1).
And questions 2, 3, 5, 7, 8, and 11 receive the following points for the checked answers: Very much like me (1 points), Mostly like me (2 points), Somewhat like me (3 points), Not much like me (4 points), Not like me at all (5 points).
Add up all the points and divide by 12.
The maximum score on this scale is 5 (extremely gritty) and the lowest score is 1 (not at all gritty).
|
Pre- and Post- 6-week supplemental period
|
Change in Emotional Health
Time Frame: Pre- and Post- 6-week supplemental period
|
Title: Visual Analog Scales; Construct: measures the intensity or frequency of various symptoms; the scale is numerical with numbers from 0 to 10 lined horizontally and 0 indicates no symptom at all, 5 indicated neutral, and 10 indicates the highest feeling of the symptom.
Symptoms asked included Hunger (0=not hungry at all, 10= very hungry), Satiety (0=don't feel full at all, 10=very full) , Mood (0= feel very down, 10= feel wonderful), Energy (0= very tired, 10=very energized), Focus (0= very distracted, 10=very focused), Alertness (0=non-coherent, 10= very aware of my surroundings)
|
Pre- and Post- 6-week supplemental period
|
Change in Emotional Health
Time Frame: Pre- and Post- 6-week supplemental period
|
Mood Disorder Questionnaire
|
Pre- and Post- 6-week supplemental period
|
Change in alcohol use
Time Frame: Pre- and Post- 6-week supplemental period
|
Alcohol Use Disorders Questionnaire
|
Pre- and Post- 6-week supplemental period
|
Change in PTSD
Time Frame: Pre- and Post- 6-week supplemental period
|
PTSD Checklist for DSM-5
|
Pre- and Post- 6-week supplemental period
|
Change in PTSD
Time Frame: Pre- and Post- 6-week supplemental period
|
Patient Health Questionnaire-9
|
Pre- and Post- 6-week supplemental period
|
Change in pain
Time Frame: Pre- and Post- 6-week supplemental period
|
Pain Outcomes Questionnaire
|
Pre- and Post- 6-week supplemental period
|
Change in PTSD
Time Frame: Pre- and Post- 6-week supplemental period
|
Adverse Childhood Experience Questionnaire
|
Pre- and Post- 6-week supplemental period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 30, 2016
Primary Completion (Anticipated)
December 1, 2019
Study Completion (Anticipated)
December 1, 2019
Study Registration Dates
First Submitted
August 5, 2019
First Submitted That Met QC Criteria
September 5, 2019
First Posted (Actual)
September 10, 2019
Study Record Updates
Last Update Posted (Actual)
November 18, 2019
Last Update Submitted That Met QC Criteria
November 15, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 907405
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PTSD
-
University of PittsburghCompletedPTSD | Non PTSDUnited States
-
Imperial College Healthcare NHS TrustImperial College LondonRecruiting
-
VA Office of Research and DevelopmentUniversity of California, San DiegoRecruiting
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Active, not recruiting
-
Oregon Health and Science UniversityEnrolling by invitation
-
VA Office of Research and DevelopmentCompleted
-
VA Office of Research and DevelopmentPortland VA Medical CenterActive, not recruiting
-
VA Office of Research and DevelopmentSan Diego Veterans Healthcare SystemCompleted
-
Creighton UniversityCompleted
-
VA Eastern KansasTerminated
Clinical Trials on Pruvit Ketomax Ketone Salt
-
Augusta UniversityFunding source: Pruvit Ventures, IncCompleted
-
University of Alabama at BirminghamWithdrawnObesity | Overweight | Overweight and Obesity | Triglycerides High
-
Université de SherbrookeSociété des Produits Nestlé (SPN)Completed
-
Université de SherbrookeNestlé Health Science SpainNot yet recruiting
-
University of British ColumbiaCompletedExercise | Dietary Supplements | KetonesCanada